Product Details:
| Strength | 50 mg |
| Brand Name | Rebopag |
| Packaging Type | Box |
| Packaging size | 4x7 |
| Composition | Rebopag 50 Mg |
| Form | Tablets |
Indication: For chronic immune thrombocytopenia (ITP), aplastic anemia, and hepatitis C-related thrombocytopenia.
Mechanism: Stimulates bone marrow to produce more platelets by activating thrombopoietin receptors.
Use: Oral tablet, taken daily.
Product Details:
| Strength | 25 mg |
| Brand Name | Rebopag |
| Manufacturer | MSNS |
| Packaging Type | Box |
| Packaging size | 4x7 |
| Form | Tablets |
Indication: For chronic immune thrombocytopenia (ITP), aplastic anemia, and hepatitis C-related thrombocytopenia.
Mechanism: Stimulates bone marrow to produce more platelets by activating thrombopoietin receptors.
Use: Oral tablet, taken daily.
Product Details:
| Strength | 75 mg |
| Brand Name | Rebopag |
| Packaging Type | Box |
| Packaging size | 4x7 |
| Composition | Rebopag 75 mg |
| Form | Tablets |
Indication: For chronic immune thrombocytopenia (ITP), aplastic anemia, and hepatitis C-related thrombocytopenia.
Mechanism: Stimulates bone marrow to produce more platelets by activating thrombopoietin receptors.
Use: Oral tablet, taken daily.